Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N02RS1 in Acute and Chronic Bronchitis
NCT01979926Phase 2Completed
- Sponsor
- PharmaKing
- Start
- Nov 2013
- Primary completion
- Nov 2013
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of PMK-N02RS1 in acute bronchitis and chronic bronchitis (CB) (3 arms), sponsored by PharmaKing. Primary endpoint: Safety at 12 weeks. Started Nov 2013; status: completed.
02
Drugs
PMK-N02RS1
03
Conditions
acute bronchitischronic bronchitis (CB)
Beyond the preview
Go deeper on NCT01979926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01979926.